Indazole derivatives as inhibitors of hormone-sensitive lipases

Details for Australian Patent Application No. 2005209366 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Heuer, Hubert; Muller, Gunter; Baringhaus, Karl-Heinz; Zoller, Gerhard; Petry, Stefan

Agent Watermark

Pub. Number AU-A-2005209366

PCT Pub. Number WO2005/073199

Priority 10 2004 005 172.0 02.02.04 DE

Filing date 15 January 2005

Wipo publication date 11 August 2005

International Classifications

C07D 231/56 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

Event Publications

24 August 2006 PCT application entered the National Phase

  PCT publication WO2005/073199 Priority application(s): WO2005/073199

9 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005209367-Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments

2005209365-7-phenylamino-4-quinolone-3-carboxyli c acid derivatives, methods for production and use thereof as medicaments